344 related articles for article (PubMed ID: 21306820)
1. The prevalence of clinically meaningful overactive bladder: bother and quality of life results from the population-based FINNO study.
Vaughan CP; Johnson TM; Ala-Lipasti MA; Cartwright R; Tammela TL; Taari K; Auvinen A; Tikkinen KA
Eur Urol; 2011 Apr; 59(4):629-36. PubMed ID: 21306820
[TBL] [Abstract][Full Text] [Related]
2. Understanding the elements of overactive bladder: questions raised by the EPIC study.
Irwin DE; Abrams P; Milsom I; Kopp Z; Reilly K;
BJU Int; 2008 Jun; 101(11):1381-7. PubMed ID: 18336602
[TBL] [Abstract][Full Text] [Related]
3. Prevalence, severity, and symptom bother of lower urinary tract symptoms among men in the EPIC study: impact of overactive bladder.
Irwin DE; Milsom I; Kopp Z; Abrams P; Artibani W; Herschorn S
Eur Urol; 2009 Jul; 56(1):14-20. PubMed ID: 19278775
[TBL] [Abstract][Full Text] [Related]
4. Nocturia frequency, bother, and quality of life: how often is too often? A population-based study in Finland.
Tikkinen KA; Johnson TM; Tammela TL; Sintonen H; Haukka J; Huhtala H; Auvinen A
Eur Urol; 2010 Mar; 57(3):488-96. PubMed ID: 19361907
[TBL] [Abstract][Full Text] [Related]
5. Effects of tolterodine ER on patient-reported outcomes in sexually active women with overactive bladder and urgency urinary incontinence.
Rogers RG; Bachmann G; Scarpero H; Jumadilova Z; Sun F; Morrow JD; Guan Z; Bavendam T
Curr Med Res Opin; 2009 Sep; 25(9):2159-65. PubMed ID: 19601704
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and effect on health-related quality of life of overactive bladder in older americans: results from the epidemiology of lower urinary tract symptoms study.
Sexton CC; Coyne KS; Thompson C; Bavendam T; Chen CI; Markland A
J Am Geriatr Soc; 2011 Aug; 59(8):1465-70. PubMed ID: 21718275
[TBL] [Abstract][Full Text] [Related]
7. Effect of bothersome overactive bladder symptoms on health-related quality of life, anxiety, depression, and treatment seeking in the United States: results from EpiLUTS.
Milsom I; Kaplan SA; Coyne KS; Sexton CC; Kopp ZS
Urology; 2012 Jul; 80(1):90-6. PubMed ID: 22748867
[TBL] [Abstract][Full Text] [Related]
8. Is the prevalence of overactive bladder overestimated? A population-based study in Finland.
Tikkinen KA; Tammela TL; Rissanen AM; Valpas A; Huhtala H; Auvinen A
PLoS One; 2007 Feb; 2(2):e195. PubMed ID: 17332843
[TBL] [Abstract][Full Text] [Related]
9. Prevalence, risk factors, and impact on health related quality of life of overactive bladder in China.
Wang Y; Xu K; Hu H; Zhang X; Wang X; Na Y; Kang X
Neurourol Urodyn; 2011 Nov; 30(8):1448-55. PubMed ID: 21826714
[TBL] [Abstract][Full Text] [Related]
10. The impact of overactive bladder on mental health, work productivity and health-related quality of life in the UK and Sweden: results from EpiLUTS.
Coyne KS; Sexton CC; Kopp ZS; Ebel-Bitoun C; Milsom I; Chapple C
BJU Int; 2011 Nov; 108(9):1459-71. PubMed ID: 21371240
[TBL] [Abstract][Full Text] [Related]
11. Relationships between improvements in symptoms and patient assessments of bladder condition, symptom bother and health-related quality of life in patients with overactive bladder treated with tolterodine.
Coyne KS; Elinoff V; Gordon DA; Deng DY; Brodsky M; Glasser DB; Jumadilova Z; Carlsson M
Int J Clin Pract; 2008 Jun; 62(6):925-31. PubMed ID: 18479285
[TBL] [Abstract][Full Text] [Related]
12. The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study.
Coyne KS; Sexton CC; Irwin DE; Kopp ZS; Kelleher CJ; Milsom I
BJU Int; 2008 Jun; 101(11):1388-95. PubMed ID: 18454794
[TBL] [Abstract][Full Text] [Related]
13. The impact of urinary urgency and frequency on health-related quality of life in overactive bladder: results from a national community survey.
Coyne KS; Payne C; Bhattacharyya SK; Revicki DA; Thompson C; Corey R; Hunt TL
Value Health; 2004; 7(4):455-63. PubMed ID: 15449637
[TBL] [Abstract][Full Text] [Related]
14. Bothersome lower urinary tract symptoms 1 year after first delivery: prevalence and the effect of childbirth.
van Brummen HJ; Bruinse HW; van de Pol G; Heintz AP; van der Vaart CH
BJU Int; 2006 Jul; 98(1):89-95. PubMed ID: 16831150
[TBL] [Abstract][Full Text] [Related]
15. OnabotulinumtoxinA improves health-related quality of life in patients with urinary incontinence due to idiopathic overactive bladder: a 36-week, double-blind, placebo-controlled, randomized, dose-ranging trial.
Fowler CJ; Auerbach S; Ginsberg D; Hale D; Radziszewski P; Rechberger T; Patel VD; Zhou J; Thompson C; Kowalski JW
Eur Urol; 2012 Jul; 62(1):148-57. PubMed ID: 22464310
[TBL] [Abstract][Full Text] [Related]
16. Symptom severity and patient perceptions in overactive bladder: how are they related?
Homma Y; Gotoh M
BJU Int; 2009 Oct; 104(7):968-72. PubMed ID: 19338560
[TBL] [Abstract][Full Text] [Related]
17. Solifenacin for overactive bladder with incontinence: symptom bother and health-related quality of life outcomes.
Garely AD; Lucente V; Vapnek J; Smith N
Ann Pharmacother; 2007 Mar; 41(3):391-8. PubMed ID: 17341526
[TBL] [Abstract][Full Text] [Related]
18. Symptom bother and health-related quality of life outcomes following solifenacin treatment for overactive bladder: the VESIcare Open-Label Trial (VOLT).
Garely AD; Kaufman JM; Sand PK; Smith N; Andoh M
Clin Ther; 2006 Nov; 28(11):1935-46. PubMed ID: 17213014
[TBL] [Abstract][Full Text] [Related]
19. What is the most bothersome lower urinary tract symptom? Individual- and population-level perspectives for both men and women.
Agarwal A; Eryuzlu LN; Cartwright R; Thorlund K; Tammela TL; Guyatt GH; Auvinen A; Tikkinen KA
Eur Urol; 2014 Jun; 65(6):1211-7. PubMed ID: 24486308
[TBL] [Abstract][Full Text] [Related]
20. A longitudinal population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in women.
Wennberg AL; Molander U; Fall M; Edlund C; Peeker R; Milsom I
Eur Urol; 2009 Apr; 55(4):783-91. PubMed ID: 19157689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]